Effect of Metformin and Megestrol in treatment of Endometrial hyperplasia

Phase 3

• Conditions: Endometrial hyperplasia.; Benign endometrial hyperplasia; N85.01

• Registration Number: IRCT20221101056361N1
• Lead Sponsor: Shahre-kord University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Endometrial Hyperplasia without Hyperplasia
No contraindication for the use of Metformin
Hb>10
GFR>30
25< BMI
18-75 years old

Exclusion Criteria

Use of Metformin in the previous 6 months
Liver disease
Malabsorption
Pregnancy
Insulin injection
Kidney disease
Alcohol consumption

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of people with EndometrIal Hyperplasia. Timepoint: The Biginning of study and three monthes later. Method of measurement: with Curettage OF endometer.